NIAID international research in infectious diseases (IRID) program (R01).
Collaborative projects involving investigators and institutions from international sites and the United States are particularly encouraged; a U.S. partner is not required. NIAID has a long-standing interest in and commitment to global health and international research. Topics of interest for this program are limited to research on infectious diseases, including emerging infections that are of the greatest public health significance within the applicant country (e.g., tuberculosis, malaria, HIV/AIDS, sexually transmitted diseases, diarrheal, respiratory, and enteric diseases, viral hemorrhagic fevers, viral encephalitides, parasitic diseases, and vector-borne diseases). Development of immunological, microbiological, biostatistical, epidemiological, and clinical research capacity is encouraged. Studies may be proposed on any aspect of infectious diseases (except clinical trials), including but not limited to the epidemiology, pathogenesis, immunopathogenesis of infectious diseases; epidemiologic studies to define the incidence, clinical presentations, and outcomes of diseases, identification of resistance patterns, characterization of susceptible cohorts for a particular pathogen; pilot and feasibility studies in preparation for larger studies.
NIAID supports a number of international research programs on infectious diseases, including HIV/AIDS. These include the International Centers of Excellence in Research (ICERs), International Collaborations for Infectious Disease Research (ICIDRs), the Tropical Medicine Research Centers (TMRCs), the Tuberculosis Research Program, the HIV Vaccine Trials Network (HVTN), and the HIV Prevention Trials Network (HPTN).
This International Research in Infectious Diseases (IRID) Program (R01) is intended to extend these programs by expanding the breadth of research supported at international sites and by providing support to new researchers. Applications from institutions in eligible countries where NIAID has significant investments through extramural research grants, cooperative agreements or contracts or through programs of the NIAID Division of Intramural Research are particularly encouraged. However, current NIH or NIAID funding is not a requirement.
Clinical trials will not be supported. When noninterventional clinical studies are a component of the research proposed, NIAID policy requires that studies be monitored commensurate with the degree of potential risk to study subjects and the complexity of the study. AN UPDATED NIAID policy was published in the NIH Guide on 8 July 2002 and is available at: http://grants.nih.gov/ grants/guide/notice-files/NOT-AI-02-032.html. The full policy, including terms and conditions of award, is available at http://www.niaid.nih.gov/ ncn/pdf/clinterm.pdf).
This Funding Opportunity Announcement (FOA) will use the NIH Research Project Grant (R01) award mechanism.
The applicant will be solely responsible for planning, directing, and executing the proposed project.
This FOA uses "Just-in-Time" information concepts. It also uses the nonmodular budget formats (see http://grants.nih.gov/grants/funding/ modular/modular.htm). All foreign applicants must complete and submit nonmodular budget requests using the Research & Related Budget component found in the application package for this FOA. See NOT-OD-06-096, 23 August 2006.
At this time, it is not known if competing renewal (formerly "competing continuation") applications will be accepted and/or if this FOA will be reissued.
Applicants must download the SF424 (R&R) application forms and the SF424 (R&R) Application Guide for this FOA through Grants.gov/Apply.
Note: Only the forms package directly attached to a specific FOA can be used. You will not be able to use any other SF424 (R&R) forms (e.g., sample forms, forms from another FOA), although some of the "Attachment" files may be useable for more than one FOA.
For further assistance, contact GrantsInfo: 301-435-0714 (telecommunications for the hearing impaired: TTY 301-451-0088) or by e-mail: GrantsInfo@nih.gov.
The application receipt dates for this PAR are 26 September 2007 and 2008. The complete version of this PAR is available at http://grants.nih. gov/grants/guide/pa-files/PAR-07-376.html.
Contacts: The complete list of agency contacts is available at http://grants.nih.gov/grants/guide/ pa-files/PAR-07-376.html. Reference: PAR-07-376.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Fellowships, Grants, & Awards|
|Publication:||Environmental Health Perspectives|
|Date:||Sep 1, 2007|
|Previous Article:||Advancing novel science in women's health research (ANSWHR) [R21].|
|Next Article:||New books.|